We are pleased to announce that the public consultation for PAS 2090:2025 – Pharmaceutical Products – Product Category Rules (PCR) for Environmental Lifecycle Assessments – Specification is now open. This is a unique opportunity to contribute to the development of a globally relevant standard that will establish a consistent methodology for assessing the environmental footprint of pharmaceutical products. The consultation closes on 10th June 2025.

All comments submitted within the defined scope will be thoroughly reviewed and discussed. You are invited to access the latest full draft version and provide your proposed changes, along with detailed technical, line-by-line commentary. Please note that all comments must be submitted electronically through the standards development portal.

BSI (British Standards Institute), which is managing the delivery of PAS 2090, is particularly seeking feedback on the following areas: is particularly seeking feedback on the following areas:

• The technical product category rules, including estimations, data availability, assessment boundaries, and lifecycle stages.
• Pilot testing within organizations to evaluate the practical application of the standard for specific product categories.
• Academic comparisons between existing product environmental or carbon footprint research and the rules established in this standard.
• Feedback from healthcare systems on the declaration and reporting section of the standards.
• Regulatory perspectives on how PAS 2090 aligns or conflicts with existing environmental or pharmaceutical regulations.

Once published, PAS 2090 will be freely accessible via the BSI Knowledge website, making it available to pharmaceutical manufacturers, LCA practitioners, and stakeholders committed to reducing environmental impacts, including greenhouse gas emissions.